CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Option exercise Chief Medical Officer acquired 6,000 shares (option exercise)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Legal Officer sold 9,492 shares at $21.96 ($208,421)
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Medical Officer sold 51,914 shares at an average $22.01 ($1,142,375)
- 4 Open-market sale Chief Legal Officer sold 45,119 shares at an average $22.10 ($996,963)
- 4 Open-market sale Chief Scientific Officer sold 21,790 shares at an average $21.64 ($471,437)
- 4 Open-market sale Chief Financial Officer sold 15,037 shares at an average $21.64 ($325,383)
- 4 Open-market sale President and CEO sold 33,260 shares at an average $21.64 ($719,735)
Page 19 of 44 · 872 filings